SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-325207
Filing Date
2021-11-10
Accepted
2021-11-10 06:44:06
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421809d8k.htm   iXBRL 8-K 26110
2 EX-99.1 d421809dex991.htm EX-99.1 46452
6 GRAPHIC g421809g1109074333382.jpg GRAPHIC 2357
  Complete submission text file 0001193125-21-325207.txt   210093

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20211110.xsd EX-101.SCH 2892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20211110_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20211110_pre.xml EX-101.PRE 11860
7 EXTRACTED XBRL INSTANCE DOCUMENT d421809d8k_htm.xml XML 3475
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 211394310
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences